Heini Salo

Summary

Affiliation: National Public Health Institute
Country: Finland

Publications

  1. ncbi request reprint [Economic evaluation of an immunization program]
    Heini Salo
    Kansanterveyslaitoksen rokotusosasto, kliininen yksikkö 00300 Helsinki
    Duodecim 118:93-7. 2002
  2. ncbi request reprint An economic evaluation of intermittent cyclosporin A therapy versus UVAB phototherapy in the treatment of patients with severe atopic dermatitis
    Heini Salo
    National Public Health Institute, Department of Vaccines, Helsinki, Finland
    Acta Derm Venereol 84:138-41. 2004
  3. ncbi request reprint Economic evaluation of pneumococcal conjugate vaccination in Finland
    Heini Salo
    Department of Vaccines, National Public Health Institute KTL, Helsinki, Finland
    Scand J Infect Dis 37:821-32. 2005
  4. pmc Impact of vaccination on 14 high-risk HPV type infections: a mathematical modelling approach
    Simopekka Vänskä
    Department of Vaccination and Immune Protection, National Institute for Health and Welfare THL, Helsinki, Finland
    PLoS ONE 8:e72088. 2013
  5. ncbi request reprint Divergent coverage, frequency and costs of organised and opportunistic Pap testing in Finland
    Heini Salo
    Department of Vaccination and Immune Protection, National Institute for Health and Welfare THL, Helsinki, Finland
    Int J Cancer 135:204-13. 2014
  6. ncbi request reprint Cost-effectiveness of influenza vaccination of healthy children
    Heini Salo
    Department of Vaccines, National Public Health Institute, KTL, 00300 Helsinki, Finland
    Vaccine 24:4934-41. 2006
  7. doi request reprint The burden and costs of prevention and management of genital disease caused by HPV in women: a population-based registry study in Finland
    Heini Salo
    Department of Vaccination and Immune Protection Vaccination Programme Unit, National Institute for Health and Welfare THL, FI 00271, Helsinki, Finland
    Int J Cancer 133:1459-69. 2013
  8. doi request reprint First year experience of rotavirus immunisation programme in Finland
    Tuija Leino
    Department of Vaccination and Immune Protection, National Institute for Health and Welfare THL, Mannerheimintie 166, Helsinki, Finland
    Vaccine 31:176-82. 2012
  9. ncbi request reprint Cost effectiveness of oral terbinafine (Lamisil) compared with oral fluconazole (Diflucan) in the treatment of patients with toenail onychomycosis
    Heini Salo
    Health Services Research Ltd, Helsinki, Finland
    Pharmacoeconomics 20:319-24. 2002

Detail Information

Publications9

  1. ncbi request reprint [Economic evaluation of an immunization program]
    Heini Salo
    Kansanterveyslaitoksen rokotusosasto, kliininen yksikkö 00300 Helsinki
    Duodecim 118:93-7. 2002
  2. ncbi request reprint An economic evaluation of intermittent cyclosporin A therapy versus UVAB phototherapy in the treatment of patients with severe atopic dermatitis
    Heini Salo
    National Public Health Institute, Department of Vaccines, Helsinki, Finland
    Acta Derm Venereol 84:138-41. 2004
    ..In terms of direct health-care costs, i.e. treatment and health services utilization costs, however, UVAB is significantly less costly, but side effects are frequent...
  3. ncbi request reprint Economic evaluation of pneumococcal conjugate vaccination in Finland
    Heini Salo
    Department of Vaccines, National Public Health Institute KTL, Helsinki, Finland
    Scand J Infect Dis 37:821-32. 2005
    ..To achieve cost savings from a health care provider (societal) perspective, without considering herd effects or replacement phenomenon, the price of PCV7 should be 50% (70%) of the price used in the base case...
  4. pmc Impact of vaccination on 14 high-risk HPV type infections: a mathematical modelling approach
    Simopekka Vänskä
    Department of Vaccination and Immune Protection, National Institute for Health and Welfare THL, Helsinki, Finland
    PLoS ONE 8:e72088. 2013
    ..Limiting the epidemiological model to infection yielded improved understanding of the hrHPV epidemiology and of mechanisms with which vaccination impacts on hrHPV infections. ..
  5. ncbi request reprint Divergent coverage, frequency and costs of organised and opportunistic Pap testing in Finland
    Heini Salo
    Department of Vaccination and Immune Protection, National Institute for Health and Welfare THL, Helsinki, Finland
    Int J Cancer 135:204-13. 2014
    ..4 million, of which 71% incurred in opportunistic screening. Of the 84,000 annual follow-up Pap tests and their €8.3 million total costs, ∼60% incurred in organised screening or in secondary health care. ..
  6. ncbi request reprint Cost-effectiveness of influenza vaccination of healthy children
    Heini Salo
    Department of Vaccines, National Public Health Institute, KTL, 00300 Helsinki, Finland
    Vaccine 24:4934-41. 2006
    ..The results show that influenza vaccination would be cost saving in all children <or=13 years of age in Finland, which advocates reconsideration of the current influenza vaccine recommendations in all countries...
  7. doi request reprint The burden and costs of prevention and management of genital disease caused by HPV in women: a population-based registry study in Finland
    Heini Salo
    Department of Vaccination and Immune Protection Vaccination Programme Unit, National Institute for Health and Welfare THL, FI 00271, Helsinki, Finland
    Int J Cancer 133:1459-69. 2013
    ..In addition opportunistic screening among this and younger age group detects a significant number of cytological abnormalities, most of which are probably treated unnecessarily...
  8. doi request reprint First year experience of rotavirus immunisation programme in Finland
    Tuija Leino
    Department of Vaccination and Immune Protection, National Institute for Health and Welfare THL, Mannerheimintie 166, Helsinki, Finland
    Vaccine 31:176-82. 2012
    ..Such studies can also be considered as a vaccine-probe-study, where unspecific disease burden prevented by immunisation is assumed to be caused by the agent the vaccine is targeted against...
  9. ncbi request reprint Cost effectiveness of oral terbinafine (Lamisil) compared with oral fluconazole (Diflucan) in the treatment of patients with toenail onychomycosis
    Heini Salo
    Health Services Research Ltd, Helsinki, Finland
    Pharmacoeconomics 20:319-24. 2002
    ..To determine the cost effectiveness of terbinafine (Lamisil) tablets compared with fluconazole (Diflucan) capsules in the treatment of patients with toenail onychomycosis...